Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

Novartis

Status and phase: Completed; Phase 3; Phase 2

Conditions: Kidney Transplantation

Treatments: Drug: FTY 720

Study type: Interventional

Funder types: Industry

Identifiers

NCT00099749

CFTY720A2218

Details and patient eligibility

About

The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Male and Female
• Between 18 to 65 years old

Exclusion criteria

• Patients in need of multiple organ transplants

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind